Client Alerts & Insights

Benesch COVID-19 Resource Center: ILLINOIS UPDATE – Gov. Pritzker Extends Protection to Health Care Facilities, Professionals and Volunteers

April 3, 2020

Authored By:

On April 1, 2020, Illinois Governor J.B. Pritzker issued an Executive Order 2020-19 (“EO”), granting “health care facilities” and “health care professionals” under the Illinois Emergency Management Agency Act (IEMA) immunity from civil liability for any injury or death that occurs while they provide health care services at a health care facility in response to the COVID-19 outbreak, unless such injury or death was caused by gross negligence or willful misconduct.

Healthcare Facilities – Per the Governor’s EO 2020-19, “health care facilities” include: ambulatory surgical treatment center, skilled and intermediate long term care facilities, specialized mental health rehab facilities, hospitals, nursing homes, among others. This definition is expected to also apply to newly erected emergency COVID-19 hospitals in locations such as McCormick Place.

Healthcare Professionals – The EO includes all licensed or certified health care or emergency medical services workers providing healthcare services at a Health Care Facility in response to COVID-19 and are authorized to do so. This is a deliberately broad definition and will include various healthcare professionals that have already answered the call to service by previous Illinois COVID-19 Executive Orders. It should be noted this EO does not appear to include immunity for “downstream” healthcare providers assisting with non-COVID-19 response, or the expansion in telemedicine services as a direct result of the COVID-19 response.

Specifically, the EO states that “health care facilities” and “health care professionals” will be immune from civil liability for any injury or death allegedly caused while engaged “in the course of rendering assistance to the State by providing health care services in response to the COVID-19 outbreak, unless it is established that such injury or death was caused by gross negligence or willful misconduct.”

The EO also extended immunity protections to “health care volunteers” meaning all volunteers or medical or nursing students.

Benesch stands ready to assist with any questions as we closely follow COVID-19 developments and support client’s response efforts.

Bob Morgan at bmorgan@beneschlaw.com or 312.624.6356.

James Ko at jko@beneschlaw.com or 312.6246367.

***

Please note that this information is current as of the date of this Client Alert, based on the available data. However, because COVID-19’s status and updates related to the same are ongoing, we recommend real-time review of guidance distributed by the CDC and local officials.

Latest News

Client Alerts & Insights 6.26.26

Supreme Court Clarifies Judicial Estoppel Standard in Bankruptcy Nondisclosure Cases

The U.S. Supreme Court rejected a rigid rule that often blocked debtors from pursuing claims they failed to disclose in bankruptcy. Courts must now look at the full circumstances before deciding whether an omission was intentional or an honest mistake.

Client Alerts & Insights 6.25.26

Federal Court Hands Major Win to Tissue Product Manufacturers – FDA’s HCT/P Classification Decision for Umbilical Cord–Derived Product CORDGRAFT Rejected

On March 18, 2026, Chief Judge Brian C. Wimes of the U.S. District Court for the Western District of Missouri issued a significant decision overturning the U.S. Food and Drug Administration’s (“FDA”) classification of Vitti Labs’ umbilical cord–derived product, CORDGRAFT.

Client Alerts & Insights 6.25.26

Science-Backed But Not FDA-Approved: New Lawsuit Challenges FDA’s Rejection of 114 Health-Related Advertising Claims

A new lawsuit challenges the FDA’s rejection of 114 health-related advertising claims for supplements, arguing that the agency’s narrow interpretation of what counts as an “authoritative statement” unfairly blocks science-backed—but not FDA-approved—claims from appearing on product labels.

Client Alerts & Insights 6.24.26

When ChatGPT Lies: What the First Wave of AI Defamation Cases Means for Plaintiffs

The common argument made by plaintiffs that differences in alleged misrepresentations are transcended by the center of the gravity of the alleged fraud should not be addressed through the typical approach of just comparing the level of variance of the representations in the case at issue with that in the relevant precedent.

View news and insights